Evidence map›Paper›PMID 19608643›Full record

ArticleMolecular endocrinology (Baltimore, Md.)2009

Negative regulation of Hedgehog signaling by liver X receptors.

Woo-Kyun Kim, Vicente Meliton, Kye Won Park, Cynthia Hong, Peter Tontonoz, Pawel Niewiadomski, James A Waschek, Sotirios Tetradis, Farhad Parhami

Open access · greenAbstract read
In one paragraph

Article in Molecular endocrinology (Baltimore, Md.), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 38 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. The wHole Story About Fenestrations in LSEC.Frontiers in physiology · 2021
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Osteogenic oxysterol, 20(S)-hydroxycholesterol, induces notch target gene expression in bone marrow stromal cells.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Woo-Kyun KimDepartment of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California 90095, USA.
Vicente Meliton
Kye Won Park
Cynthia Hong
Peter Tontonoz
Pawel Niewiadomski
James A Waschek
Sotirios Tetradis
Farhad Parhami
University of California, Los Angeles · USHoward Hughes Medical Institute · USWest Los Angeles College · USSungkyunkwan University · KR

Funding

Oxysterols Regulate Marrow Stromal Cell DifferentiationR01AR050426 · NIAMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI PARHAMI, FARHAD · 2005 to 2009
$1.6M
NIAMS NIH HHS R01 AR050426
6 · The paper itself

Abstract

Hedgehog (Hh) signaling is indispensable in embryonic development, and its dysregulated activity results in severe developmental disorders as shown by genetic models of naturally occurring mutations in animal and human pathologies. Hh signaling also functions in postembryonic development and adult tissue homeostasis, and its aberrant activity causes various human cancers. Better understanding of molecular regulators of Hh signaling is of fundamental importance in finding new strategies for pathway modulation. Here, we identify liver X receptors (LXRs), members of the nuclear hormone receptor family, as previously unrecognized negative regulators of Hh signaling. Activation of LXR by specific pharmacological ligands, TO901317 and GW3965, inhibited the responses of pluripotent bone marrow stromal cells and calvaria organ cultures to sonic Hh, resulting in the inhibition of expression of Hh-target genes, Gli1 and Patched1, and Gli-dependent transcriptional activity. Moreover, LXR ligands inhibited sonic Hh-induced differentiation of bone marrow stromal cells into osteoblasts. Elimination of LXRs by small interfering RNA inhibited ligand-induced inhibition of Hh target gene expression. Furthermore, LXR ligand did not inhibit Hh responsiveness in mouse embryonic fibroblasts that do not express LXRs, whereas introduction of LXR into these cells reestablished the inhibitory effects. Daily oral administration of TO901317 to mice after 3 d significantly inhibited baseline Hh target-gene expression in liver, lung, and spleen. Given the importance of modulating Hh signaling in various physiological and pathological settings, our findings suggest that pharmacological targeting of LXRs may be a novel strategy for Hh pathway modulation.

Indexed as

Signal TransductionAnimalsBenzenesulfonamidesBenzoatesBenzylaminesBone Marrow CellsCell DifferentiationCiliaFibroblastsFluorocarbonsGene Expression RegulationGenes, ReporterHedgehog ProteinsHumansHydrocarbons, FluorinatedLigandsBenzenesulfonamidesBenzoatesBenzylaminesFluorocarbonsGW 3965Hedgehog ProteinsHydrocarbons, FluorinatedLigandsLiver X ReceptorsMorpholinesOncogene ProteinsOrphan Nuclear ReceptorsPatched-1 ReceptorPatched ReceptorsPTCH1 protein, humanPtch1 protein, mousePurinespurmorphamineReceptors, Cell SurfaceRNA, MessengerRNA, Small InterferingShh protein, mouseSulfonamidesT0901317Trans-ActivatorsZinc Finger Protein GLI1

Identifiers

PMID19608643
PMCPMC2754896
OpenAlexW2142003104

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.